Stock EGRX EAGLE PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Eagle Pharmaceuticals, Inc.

Equities

EGRX

US2697961082

Pharmaceuticals

Real-time Estimate Cboe BZX
Other stock markets
 10:53:42 2024-04-25 am EDT 		5-day change 1st Jan Change
4.36 USD -4.18% Intraday chart for Eagle Pharmaceuticals, Inc. -2.68% -16.63%
Apr. 22 North American Morning Briefing : Stock Futures -2- DJ
Apr. 15 Sector Update: Health Care Stocks Softer Late Afternoon MT

Business Summary

Eagle Pharmaceuticals, Inc. is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial capabilities. The Company is focused on developing medicines that result in improvements in patients' lives. The Company's commercialized products include vasopressin, PEMFEXY, RYANODEX, BENDEKA, BELRAPZO, TREAKISYM (Japan), and BYFAVO and BARHEMSYS through its wholly owned subsidiary Acacia Pharma Inc. Its oncology and central nervous system (CNS)/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. The Company also has a research and development facility in Cambridge, Massachusetts. The Company has office space in Palm Beach Gardens, Florida and Indianapolis, Indiana. The Company’s subsidiaries include Eagle Biologics, Inc., Eagle Research Lab Limited, Acacia Pharma Group plc, Acacia Pharma Limited and Acacia Pharma Inc.

Number of employees: 134

Sales per Business

USD in Million2021Weight2022Weight Delta
Injectable Drugs
100.0 %
172 100.0 % 317 100.0 % +84.56%

Sales per region

USD in Million2021Weight2022Weight Delta
United States
100.0 %
172 100.0 % 317 100.0 % +84.56%

Managers

Managers TitleAgeSince
Michael Graves CEO
 Chief Executive Officer 61 13-10-31
Steven B. Ratoff DFI
 Director of Finance/CFO 81 07-02-28
Ryan Debski CMP
 Compliance Officer - 21-04-30
Reed McClung PRN
 Corporate Officer/Principal - -
John Kimmet SAM
 Sales & Marketing - 19-12-31
Debra M. Hussain PRN
 Corporate Officer/Principal - 22-07-17
Daniel O'Connor PRN
 Corporate Officer/Principal - 06-12-31
Charles Wescott PRN
 Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Steven B. Ratoff DFI
 Director of Finance/CFO 81 07-02-28
Jennifer Simpson BRD
 Director/Board Member 55 19-08-27
Richard Edlin BRD
 Director/Board Member 63 17-03-16
Michael Graves CEO
 Chief Executive Officer 61 13-10-31
Robert Glenning BRD
 Director/Board Member 63 16-06-30
Luciana Borio BRD
 Director/Board Member 53 21-04-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 17,539,701 11,425,564 ( 65.14 %) 4,552,730 ( 25.96 %) 65.14 %

Shareholders

NameEquities%Valuation
Scott Tarriff
11.19 %
1,453,244 11.19 % 8 M $
AIGH Capital Management LLC
8.174 %
1,061,509 8.174 % 6 M $
BlackRock Advisors LLC
7.105 %
922,745 7.105 % 5 M $
Janus Henderson Investors US LLC
5.972 %
775,525 5.972 % 4 M $
Brandes Investment Partners LP
5.737 %
745,080 5.737 % 4 M $
Vanguard Fiduciary Trust Co.
4.914 %
638,124 4.914 % 3 M $
Millennium Management LLC
4.023 %
522,402 4.023 % 3 M $
AQR Capital Management LLC
3.801 %
493,665 3.801 % 3 M $
LSV Asset Management
3.017 %
391,758 3.017 % 2 M $
Morgan Stanley Investment Management, Inc.
2.286 %
296,864 2.286 % 2 M $

Company contact information

Eagle Pharmaceuticals, Inc.

50 Tice Boulevard Suite 315

07677-9991, Woodcliff Lake

+201 326 5300

http://www.eagleus.com
address Eagle Pharmaceuticals, Inc.(EGRX)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Quarterly earnings - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
EAGLE PHARMACEUTICALS, INC. Stock Eagle Pharmaceuticals, Inc.
-16.63% 59.09M
MERCK KGAA Stock Merck KGaA
+4.06% 70.78B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+10.72% 9.15B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-15.34% 4.84B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+34.54% 4.22B
YUHAN CORPORATION Stock Yuhan Corporation
+5.09% 3.92B
INDIVIOR PLC Stock Indivior PLC
+16.03% 2.55B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-24.15% 2.26B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-28.33% 2.24B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+6.23% 1.92B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. EGRX Stock
  4. Company Eagle Pharmaceuticals, Inc.